CareScience tightens belt, lays off 15% of staff

Article

Online care management firm CareScience cut 22 employees (15%) and consolidated operations in an effort to reduce expenses and achieve profitability by the end of the year. The firm has centralized company marketing and product development,

Online care management firm CareScience cut 22 employees (15%) and consolidated operations in an effort to reduce expenses and achieve profitability by the end of the year. The firm has centralized company marketing and product development, following the discontinuation of the CareLeader and CareSense product lines. The move comes on the heels of CareScience's acquisition of Strategic Outcomes Services, a pharmacoeconomic and outcomes research consulting firm. The deal cost CareScience $1.1 million in cash and 250,000 shares of common stock, but the company expects the acquisition to have a positive impact on its 2001 earnings.

In other news, CareScience will integrate Intel Internet Authentication Services into Care Data Exchange, which uses peer-to-peer technology to securely locate and index clinical data from participating healthcare organizations, and CareStandard Select, which enables users to select health information products online. The company has also announced a contract to provide group purchasing organization AmeriNet with clinical data analysis tools.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.